BIOMAT Database Logo BIOMAT Database Logo

Effect of a sequential oestrogen-progestin therapy on the plasma level of oestrogens and lipids in post-menopausal women. 1979

L Lillienberg, and H Adlercreutz, and A Svanborg

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008594 Menopause, Premature The premature cessation of menses (MENSTRUATION) when the last menstrual period occurs in a woman under the age of 40. It is due to the depletion of OVARIAN FOLLICLES. Premature MENOPAUSE can be caused by diseases; OVARIECTOMY; RADIATION; chemicals; and chromosomal abnormalities. Premature Menopause
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009640 Norethindrone A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for CONTRACEPTION. 19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-, (17alpha)-,Ethinylnortestosterone,Norethisterone,Norpregneninolone,Conceplan,Micronor,Monogest,Nor-QD,Norcolut,Norcolute,Norethindrone, (1 beta)-Isomer,Norlutin,Nor QD,NorQD
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D002369 Castration Surgical removal or artificial destruction of gonads. Gonadectomy,Castrations,Gonadectomies
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot

Related Publications

L Lillienberg, and H Adlercreutz, and A Svanborg
Oestrogen--progestin therapy and the lipid balance of post-menopausal women.
December 1982, Maturitas,
L Lillienberg, and H Adlercreutz, and A Svanborg
Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
June 1989, Maturitas,
L Lillienberg, and H Adlercreutz, and A Svanborg
Glucose tolerance, plasma insulin and lipids in postmenopausal women during sequential oestrogen-progestin treatment.
January 1971, Acta obstetricia et gynecologica Scandinavica. Supplement,
L Lillienberg, and H Adlercreutz, and A Svanborg
Oestrogen plus progestin doubles the risk of dementia in post-menopausal women.
November 2003, Evidence-based mental health,
L Lillienberg, and H Adlercreutz, and A Svanborg
Effect of oestrogen replacement therapy on bone mass in post-menopausal Bangladeshi women.
December 2001, Bangladesh Medical Research Council bulletin,
L Lillienberg, and H Adlercreutz, and A Svanborg
Effects of conjugated equine oestrogens and oestriol on blood clotting, plasma lipids and endometrial proliferation in post-menopausal women.
August 1981, Maturitas,
L Lillienberg, and H Adlercreutz, and A Svanborg
Plasma zinc in pre- and post-menopausal women: its relationship to oestrogen therapy.
January 1973, Clinical science,
L Lillienberg, and H Adlercreutz, and A Svanborg
Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women.
November 1987, Maturitas,
L Lillienberg, and H Adlercreutz, and A Svanborg
Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.
March 1984, Maturitas,
L Lillienberg, and H Adlercreutz, and A Svanborg
Effect of estrogen-progestin replacement therapy on plasma lipids and lipoproteins in postmenopausal women.
May 2000, Endocrine research,
Copied contents to your clipboard!